Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III

Raizy Gruda, Alice C. N. Brown, Valentin Grabovsky, Saar Mizrahi, Chamutal Gur, Sara W. Feigelson, Hagit Achdout, Yotam Bar-on, Ronen Alon, Memet Aker, Daniel M. Davis, Ofer Mandelboim

Blood (2012) 120 (19): 3915–3924.

https://doi.org/10.1182/blood-2012-02-410795

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Kindlin-3 is required for the stabilization of TCR-stimulated LFA-1:ICAM-1 bonds critical for lymphocyte arrest and spreading on dendritic cells

Sara W. Feigelson, Valentin Grabovsky, Eugenia Manevich-Mendelson, Ronit Pasvolsky, Ziv Shulman, Vera Shinder, Eugenia Klein, Amos Etzioni, Memet Aker, Ronen Alon

Blood (2011) 117 (26): 7042–7052.

https://doi.org/10.1182/blood-2010-12-322859

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

The Optimal Initiation Timing for Cyclosporine in Allogeneic Transplantation, Earlier Is Better with the Price of Higher Rate of Chronic Gvhd.

Liliane Dray, Aliza Matusevich, Igor Resnick, Memet Aker, M.D, Simcha Samuel, Reuven Or, Michael Y. Shapira, MD

Blood (2009) 114 (22): 1143.

https://doi.org/10.1182/blood.V114.22.1143.1143

Published: 2009

Journal Articles

Alefacept Treatment for Graft Vs. Host Disease May Not Suppress the Graft Vs. Leukemia Effect.

Liliane Dray, Aliza Matusevich, Igor Resnick, Memet Aker, M.D, Polina Stepansky, Reuven Or, Michael Y. Shapira, MD

Blood (2009) 114 (22): 2223.

https://doi.org/10.1182/blood.V114.22.2223.2223

Published: 2009

Journal Articles

Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions

Eugenia Manevich-Mendelson, Sara W. Feigelson, Ronit Pasvolsky, Memet Aker, Valentin Grabovsky, Ziv Shulman, Sara Sebnem Kilic, Maria Alessandra Rosenthal-Allieri, Shifra Ben-Dor, Adi Mory, Alain Bernard, Markus Moser, Amos Etzioni, Ronen Alon

Blood (2009) 114 (11): 2344–2353.

https://doi.org/10.1182/blood-2009-04-218636

Published: 2009

Includes: Supplemental data

Journal Articles

Hemin Augments Growth and Hemoglobinization of Erythroid Precursors Derived from Patients with Diamond-Blackfan Anemia (DBA).

Eitan Fibach, Ph.D, Memet Aker, M.D.

Blood (2008) 112 (11): 2037.

https://doi.org/10.1182/blood.V112.11.2037.2037

Published: 2008

Journal Articles

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

Michael Y. Shapira, MD, Allan I. Bloom, MD, Reuven Or, MD, Igor B. Resnick, MD, PhD, DSc, Memet Aker, MD, Shimon Slavin, MD, Anthony Verstandig, MD

Blood (2007) 110 (11): 4960.

https://doi.org/10.1182/blood.V110.11.4960.4960

Published: 2007

Journal Articles

NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome

Roi Gazit, Memet Aker, Moran Elboim, Hagit Achdout, Gil Katz, Dana G. Wolf, Shulamit Katzav, Ofer Mandelboim

Blood (2007) 109 (10): 4306–4312.

https://doi.org/10.1182/blood-2006-09-047159

Published: 2007

Journal Articles

Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes While Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignances.

Shimon Slavin, MD, Michael Y. Shapira, MD, Igor B. Resnick, MD, Menachem Bitan, MD, Memet Aker, MD, Simcha Samuel, MSc, Shoshana Morecki, PhD, Reuven Or, MD

Blood (2006) 108 (11): 5157.

https://doi.org/10.1182/blood.V108.11.5157.5157

Published: 2006

Journal Articles

Effective Treatment of Resistant Hematological Malignancies by IL-2 Activated NK Cells Using Haploidentically Mismatched Donors by Induction of Graft-Versus-Tumor (GVT) Effect While Avoiding GVHD.

Shimon Slavin, MD, Reuven Or, MD, Aliza Ackerstein, MSc, Simcha Samuel, MSc, Michael Y. Shapira, MD, Igor Resnick, MD, Menachem Bitan, MD, Memet Aker, MD, Yael Gelfand, MSc, Osnat Eizik, Shoshana Morecki, PhD

Blood (2005) 106 (11): 5400.

https://doi.org/10.1182/blood.V106.11.5400.5400

Published: 2005

Journal Articles

Treatment of Resistant Leukemia by rIL-2 Activated NK Cells in Recipients of HLA Matched and Haploidentically Mismatched Stem Cell Allografts while Avoiding GVHD.

Shimon Slavin, MD, Reuven Or, MD, Memet Aker, MD, Michael Y. Shapira, MD, Igor B. Resnick, MD, Menachem Bitan, MD, Svetlana Miron, MD, Irina Zilberman, MD, Simcha Samuel, MSc, Yael Gelfand, MSc, Corinne Nabet, Osnat Isaacs, Aliza Ackerstein, MSc, Shoshana Morecki, PhD

Blood (2004) 104 (11): 5180.

https://doi.org/10.1182/blood.V104.11.5180.5180

Published: 2004

Journal Articles

LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds

Tatsuo Kinashi, Memet Aker, Maya Sokolovsky-Eisenberg, Valentin Grabovsky, Chisato Tanaka, Revital Shamri, Sara Feigelson, Amos Etzioni, Ronen Alon

Blood (2004) 103 (3): 1033–1036.

https://doi.org/10.1182/blood-2003-07-2499

Published: 2004

Journal Articles

A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow

Ronen Alon, Memet Aker, Sara Feigelson, Maya Sokolovsky-Eisenberg, Donald E. Staunton, Guy Cinamon, Valentin Grabovsky, Revital Shamri, Amos Etzioni

Blood (2003) 101 (11): 4437–4445.

https://doi.org/10.1182/blood-2002-11-3427

Published: 2003

Journal Articles

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

Reuven Or, Michael Y. Shapira, Igor Resnick, Avraham Amar, Aliza Ackerstein, Simcha Samuel, Memet Aker, Elizabeth Naparstek, Arnon Nagler, Shimon Slavin

Blood (2003) 101 (2): 441–445.

https://doi.org/10.1182/blood-2002-02-0535

Published: 2003

Journal Articles

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, Ella Naparstek, Yossi Kapelushnik, Memet Aker, Gabriel Cividalli, Gabor Varadi, Mark Kirschbaum, Aliza Ackerstein, Simcha Samuel, Avraham Amar, Chaim Brautbar, Ofira Ben-Tal, Amiram Eldor, Reuven Or

Blood (1998) 91 (3): 756–763.

https://doi.org/10.1182/blood.V91.3.756

Published: 1998

NARROW

Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III

Kindlin-3 is required for the stabilization of TCR-stimulated LFA-1:ICAM-1 bonds critical for lymphocyte arrest and spreading on dendritic cells

The Optimal Initiation Timing for Cyclosporine in Allogeneic Transplantation, Earlier Is Better with the Price of Higher Rate of Chronic Gvhd.

Alefacept Treatment for Graft Vs. Host Disease May Not Suppress the Graft Vs. Leukemia Effect.

Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions

Hemin Augments Growth and Hemoglobinization of Erythroid Precursors Derived from Patients with Diamond-Blackfan Anemia (DBA).

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome

Long-Term Safety and Efficacy of Stem Cell Gene Therapy for ADA-SCID.

Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes While Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignances.

Effective Treatment of Resistant Hematological Malignancies by IL-2 Activated NK Cells Using Haploidentically Mismatched Donors by Induction of Graft-Versus-Tumor (GVT) Effect While Avoiding GVHD.

Treatment of Resistant Leukemia by rIL-2 Activated NK Cells in Recipients of HLA Matched and Haploidentically Mismatched Stem Cell Allografts while Avoiding GVHD.

LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds

A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only